DSI - DS InPharmatics, a PLG company’s Post

Cell & Gene Therapy (CGT) are exciting therapeutic modalities which bring us closer to our goal of curing disease. This CGT pitching session at the #SwissBiotechDay will showcase innovative companies at various stages of development. The focus will delve into three key facets of deploying CGT to address diverse medical needs: (i) gene therapy for genetically defined disorders, (ii) recent strides in CGT within immune-oncology, and (iii) advancements in tackling autoimmunity. Avrion Therapeutics Tigen T-CURX GmbH Antion Biosciences SA Advesya CSL Behring B.V. Novartis J&J Innovative Medicine Europe, Middle East & Africa (EMEA) Markus Kalousek BGV (BioGeneration Ventures) #swissbiotechday, #genetherapy, #CGT, #innovation

Dive into a decade of health breakthroughs! 🚀 The approval of cell and gene therapies has paved the way for transformative outcomes for patients. Discover the FDA's expert guidance as they navigate companies through the CMC requirements process, ensuring the approval of products that mend and rejuvenate human cells to combat diseases. 🧬 Explore the journey here: https://bit.ly/3CHNrmg #HealthInnovation #FDAInsights #CMCRequirements

We are proud to shine the spotlight on NecstGen in our latest customer story! NecstGen is a leading center for the clinical advancement of cell and gene therapies. They are doing amazing work enabling the next generation of therapies for patients. With Leapwork, NecstGen has fully automated its testing practice, ensuring constant GxP-compliance and operational efficiency. Their small testing team now influences product development, contributing 270 new features to the product roadmap over the last two years. Dive into the comments for the full story. #TestAutomation #ContinuousTesting #Healthcare #GxPCompliance

Technological advances in gene and cell therapy are becoming one of the most important issues affecting insurance payors and entities taking healthcare risk. PartnerRe takes a client-centered approach to protecting our clients from financial volatility caused by gene and cell therapy claims by offering customized solutions to fit our client’s risk appetite and unique coverage needs. The number of new therapies expected to be approved by the FDA is increasing. We continually monitor the effects of high-cost therapies on the market and provide our clients with educational updates and insights

Hoping to see you soon at our upcoming webinar!

The evolving landscape of gene & cell therapy has a profound impact on the healthcare insurance industry. In this new article, we look at the challenges and implications the industry faces as approvals for gene & cell therapies continue to rise. #genetherapy #celltherapy  Learn more: https://lnkd.in/e_bgZFim

Dive into a decade of health breakthroughs! 🚀 The approval of cell and gene therapies has paved the way for transformative outcomes for patients. Discover the FDA's expert guidance as they navigate companies through the CMC requirements process, ensuring the approval of products that mend and rejuvenate human cells to combat diseases. 🧬 Explore the journey here: https://lnkd.in/en8_UwJc #HealthInnovation #FDAInsights #CMCRequirements

It can take 10+ years to develop a safe and effective #cellandgenetherapy for patients, a process often complicated by the challenges associated with progressing innovative R&D processes to standardized and robust manufacturing methods. Thermo Fisher Scientific has responded to this industry challenge by developing our Rapid Development Framework™, which can streamline the complexity of #regenerativemedicine and #immunotherapy workflows for cell and gene therapies. Our upcoming webinar in partnership with #PharmaIgnite will take a deep dive into this framework, exploring how it can expedite #drugdevelopment and manufacturing timelines while staying adaptable to the unique needs of each product. Register here: http://spr.ly/6044g0Qj4

Exciting developments in healthcare are reshaping the landscape, bringing hope and innovation to the forefront. From groundbreaking gene therapies to advancements in AI-driven diagnostics, the pace of progress is remarkable. These strides not only improve patient care but also inspire collaboration and creativity across the industry. Let's embrace these advancements and continue driving positive change in healthcare together! #HealthcareInnovation #MedicalAdvances #RoboticTransplants

🔬💉 Exciting news in the world of medicine! 🌟 Could Pfizer's Gene Therapy be the game-changer for Hemophilia B patients? 🤔 Dive into the controversy surrounding Beqvez and its potential impact on over 7,000 Americans. 💪 #GeneTherapy #HemophiliaB #MedicalInnovation Are you ready to explore the future of rare disease treatments? Click the to learn more and join the discussion! 🚀💊 #Pfizer #HealthcareRevolution #StayInformed article: https://buff.ly/4dijN7B